Welcome to our dedicated page for Genworth Finl SEC filings (Ticker: GNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Genworth Financial, Inc. (NYSE: GNW) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports, annual reports, and quarterly reports filed with the U.S. Securities and Exchange Commission. As a publicly traded holding company with operations in long-term care insurance, life and annuities, and U.S. mortgage insurance through Enact Holdings, Inc. (Nasdaq: ACT), Genworth uses these filings to present detailed financial and segment information.
Investors reviewing GNW SEC filings can examine how Genworth reports results for its Enact, Long-Term Care Insurance, and Life and Annuities segments, along with holding company activities. Filings such as Form 10-K and Form 10-Q typically include discussions of net income, adjusted operating income, segment performance, investment results, statutory capital measures, and risk-based capital ratios for U.S. life insurance subsidiaries. They also describe Genworth’s use of non-GAAP measures, including how adjusted operating income is defined and reconciled to GAAP net income.
Current reports on Form 8-K, such as the filing dated November 5, 2025, document material events including the release of quarterly financial results and the availability of related press releases and financial supplements. These filings often reference exhibits that contain detailed data tables and segment disclosures.
Through Stock Titan, users can follow GNW filings in real time as they are posted to the SEC’s EDGAR system. AI-powered tools summarize lengthy documents, highlight key themes such as capital allocation, share repurchase authorizations, segment trends, and legal or regulatory updates, and help clarify the implications of complex items like liability remeasurement in long-term care, reserve releases in mortgage insurance, or changes in market risk benefits. The filings page can also surface insider transaction reports on Form 4 and proxy-related disclosures when available, giving a fuller view of executive and governance-related information.
Woodell Darren W. reported acquisition or exercise transactions in this Form 4 filing.
Genworth Financial reported that VP and Controller Darren W. Woodell received a grant of 18,743 cash-settled restricted stock units. The award is recorded at a price of $0.00 per unit, reflecting compensation rather than an open-market purchase.
According to the terms, each unit represents a contingent right to receive a cash payment equal to the value of one share of Genworth common stock on each of March 2, 2027, March 2, 2028 and March 2, 2029. After this grant, Woodell holds 18,743 such units directly.
Genworth Financial President and CEO Thomas J. McInerney exercised 665,574 Performance Stock Units that fully vested on March 2, 2026, receiving common shares on a 1:1 basis. To cover related tax obligations, the company withheld 304,135 shares at $8.46 per share. After these transactions, he held 5,468,883 shares directly and 89,456 shares indirectly through trusts for children.
Genworth Financial EVP & CFO Jerome T. Upton reported equity compensation and related share movements in company stock. He received a grant of 91,429 Restricted Stock Units at no cost, which settle into Common Stock on a 1:1 basis and vest in three equal installments beginning on March 2, 2027.
On March 2, 2026, Performance Stock Units granted on February 16, 2023 fully vested and were settled in Common Stock on a 1:1 basis, adding 83,196 shares of Common Stock. To cover tax withholding on the vested Performance Stock Units, the company withheld 36,555 shares of Common Stock at $8.46 per share. After these transactions, Upton directly held 560,388 shares of Common Stock and 91,429 Restricted Stock Units.
Genworth Financial executive Taylor C. Morris, EVP & CIO, received a grant of 45,714 Restricted Stock Units on March 2, 2026. These RSUs settle into common stock on a 1:1 basis. They are scheduled to vest and convert to common shares in three equal installments beginning on March 2, 2027.
Genworth Financial executive Samir B. Shah, President & CEO of CareScout Services, reported several equity compensation moves. He received a grant of 102,857 Restricted Stock Units, which settle into common stock on a 1:1 basis and vest in three equal installments beginning on March 2, 2027. Separately, Performance Stock Units granted on February 16, 2023 fully vested on March 2, 2026 and were settled into 36,381 shares of common stock. To cover tax withholding for the vested performance units, 18,595 shares of common stock were withheld at a price of $8.46 per share, leaving Shah with 115,954 common shares held directly after these transactions.
Genworth Financial executive Kelly A. Saltzgaber reported equity compensation and related share movements. On
On the same date, Performance Stock Units granted on
Genworth Financial executive Gregory S. Karawan reported multiple equity transactions. He received a grant of 68,571 Restricted Stock Units, which settle into an equal number of Genworth common shares and vest in three equal installments beginning on March 2, 2027.
On March 2, 2026, 49,918 Performance Stock Units granted on February 16, 2023 fully vested and were settled 1:1 into common stock. To cover related tax withholding, the company withheld 22,514 common shares at a price of $8.46 per share. After these transactions, Karawan directly held 383,121 common shares and indirectly held 4,738.157 shares through a 401(k) plan.
Genworth Financial’s EVP and Chief Risk Officer Mark Blakeley Hodges reported equity-related transactions. He acquired 45,714 Restricted Stock Units at $0.0000 per unit, which settle into common stock on a 1:1 basis and vest in three equal installments beginning on March 2, 2027.
He also acquired 49,918 shares of Common Stock through the exercise and settlement of previously granted Performance Stock Units that fully vested on March 2, 2026. To satisfy tax withholding on these vested units, 22,514 shares of Common Stock were disposed of at $8.4600 per share. Following these transactions, he directly owned 166,515 shares of Common Stock and indirectly held 4,532.6110 shares through a 401(k) plan.
Genworth Financial executive Melissa Hagerman reported several equity compensation transactions. She received a grant of 57,143 Restricted Stock Units that settle one-for-one in common shares and vest in three equal installments beginning on March 2, 2027. She also acquired 49,918 common shares through the vesting and settlement of previously granted Performance Stock Units and disposed of 22,514 common shares at
Genworth Financial executive Jamala M. Arland, President & CEO of U.S. Life Insurance, reported several equity-related transactions. She acquired 82,286 Restricted Stock Units at no cost, which settle into common stock on a 1:1 basis and vest in three equal installments beginning on March 2, 2027. She also acquired 24,959 shares of common stock through the exercise or conversion of a derivative security, and then disposed of 11,257 shares of common stock to cover tax withholding obligations tied to Performance Stock Units that vested on March 2, 2026. After these transactions, she directly owned 101,657 shares of Genworth common stock.